Short communicationDecreased metabotropic glutamate receptor type 1 availability in a patient with spinocerebellar ataxia type 6: A 11C-ITMM PET study
Introduction
Metabotropic glutamate receptor type 1 (mGluR1) is involved in excitatory neurotransmission [1]. The regulation of mGluR1 is important in the pathophysiology of several neurological and psychiatric disorders. Imaging of mGluR1 in living human brains has recently been made possible using positron emission tomography (PET) along with the finding that mGluR1 in healthy subjects is exclusively localized to the cerebellar cortex [2]. As the expression of mGluR1 predominates postsynaptically in the cerebellar Purkinje cells and is involved in the regulation of cerebellar function [1], in vivo imaging of mGluR1 may provide crucial information for understanding the pathophysiology in cerebellar disorders. Spinocerebellar ataxia type 6 (SCA6) is one of the inherited cerebellar disorders, demonstrating relatively pure cerebellar symptoms due to selective Purkinje cell degeneration [3], [4]. Here we show the initial mGluR1 imaging in a patient with SCA6 and discuss its usefulness.
Section snippets
Research participants
The Ethics Committee of the Tokyo Metropolitan Institute of Gerontology approved the study protocol and written informed consent was obtained from all participants. The subjects comprised a patient with SCA6 and 9 age-matched healthy controls [3 men and 6 women; 71.6 ± 5.0 years (mean age ± SD)]. All participants underwent PET and magnetic resonance imaging (MRI) scans.
Characteristics of the patient with spinocerebellar ataxia type 6
The patient was a 74-year-old woman. She experienced dizziness during her middle 50s, developed imbalance in her 60s, and visited
Results
The BPND values before and after the partial volume correction in the patient were 38.1% to 65.2% and 51.0% to 68.3%, respectively, of the controls (Table 1). Of the cerebellar subregions, relatively reduced values of BPND were found in the vermis and flocculus. The volume of the whole cerebellum in the patient (Fig. 2A) was 72.6% of the controls. The BPND maps in the patient are displayed in native space (Fig. 2B and C). The BPND maps in 9 healthy controls were averaged in MNI space after they
Discussion
We present the initial imaging of mGluR1 in a patient with SCA6. SCA6 is clinically characterized by late-onset and slowly progressive pure cerebellar symptoms. Neurodegeneration in SCA6 is usually confined to the cerebellum and is less severe in other brain regions. Histologically, cerebellar atrophy is particularly seen in the vermis due to the selective loss of Purkinje cells [3], [4]. The mGluR1 expression is abundant in the dendritic arbors of Purkinje cells facing synaptic terminals of
Disclosure
None of the authors has any conflict of interest to disclose.
Acknowledgments
The authors thank Ms. Hatsumi Endo and Mr. Kunpei Hayashi for their technical assistance. This study was supported by a Grant-in-Aid for Scientific Research (B) No. 24390298 from the Japan Society for the Promotion of Science.
References (14)
- et al.
Preclinical and the first clinical studies on [11C]ITMM for mapping metabotropic glutamate receptor subtype 1 by positron emission tomography
Nucl. Med. Biol.
(2013) - et al.
Simplified reference tissue model for PET receptor studies
NeuroImage
(1996) - et al.
Metabotropic glutamate 1 receptor: current concepts and perspectives
Pharmacol. Rev.
(2008) - et al.
Clinical, neuropathological, and molecular study in two families with spinocerebellar ataxia type 6 (SCA6)
J. Neurol. Neurosurg. Psychiatry
(1999) - et al.
Spinocerebellar ataxia type 6: gaze-evoked and vertical nystagmus, Purkinje cell degeneration, and variable age of onset
Ann. Neurol.
(1997) - et al.
Noise reduction in the simplified reference tissue model for neuroreceptor functional imaging
J. Cereb. Blood Flow Metab.
(2002) - et al.
In vivo imaging of the metabotropic glutamate receptor 1 (mGluR1) with positron emission tomography: recent advance and perspective
Curr. Med. Chem.
(2014)
Cited by (7)
Age and gender effects of <sup>11</sup>C-ITMM binding to metabotropic glutamate receptor type 1 in healthy human participants
2017, Neurobiology of AgingCitation Excerpt :The rank order of VT values corresponds well to the estimated mGluR1 density in the human brain (Toyohara et al., 2013b). A recent case report study with 11C-ITMM in patients with spinocerebellar ataxia type 6 suggests that the magnitude of mGluR1 density reduction in the cerebellum is larger than the volumetric changes observed with magnetic resonance imaging (MRI; Ishibashi et al., 2015). Although these findings are promising, no information has been published regarding age and gender effects of mGluR1 density in healthy participants.
Comparison of imaging using <sup>11</sup>C-ITMM and <sup>18</sup>F-FDG for the detection of cerebellar ataxia
2017, Journal of the Neurological SciencesCitation Excerpt :The cerebellar ataxia group consisted of 3 patients with SCA6, 3 patients with SCA19/22, and 6 patients with sporadic SCA (2 men and 4 women; aged 70.3 ± 13.3 years). Their clinical characteristics are described elsewhere [7,9]. Briefly, the patients with SCA6 were a 31-year-old man, a 68-year-old woman, and a 74-year-old woman with the SARA scores of 2, 21, and 6.5, respectively.
A review of molecular imaging of glutamate receptors
2020, MoleculesCurrent radioligands for the PET imaging of metabotropic glutamate receptors
2020, PET and SPECT of Neurobiological SystemsAdvances in CNS PET: the state-of-the-art for new imaging targets for pathophysiology and drug development
2020, European Journal of Nuclear Medicine and Molecular ImagingRelationship between type 1 metabotropic glutamate receptors and cerebellar ataxia
2016, Journal of Neurology